The COVID-19 global pandemic has plagued the world and crippled many economies, taking millions of lives. With the emergence of newer and more potent variants of this virus, it is imperative to remain up to date with novel treatment modalities. Medical therapeutics has been the mainstay treatment and preventive measures used by most nations to prevent widespread disease. With the discovery of oral therapeutics that can reduce the potency of the COVID-19 infection, it is important that we tackle another global health issue – inequitable distribution of healthcare resources. This article aims to address the ethical concerns of allocation of scarce drugs, and a tiered approach to prevent misuse of such oral therapeutics. Scarce resources must be protected and distributed based on a needs basis, to improve healthcare worldwide and alleviate suffering from this pandemic.